EGF, epidermal growth factor, 1950

N. diseases: 774; N. variants: 33
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0152018
Disease: Esophageal carcinoma
Esophageal carcinoma
0.100 Biomarker disease BEFREE To address this problem, we generated oligonucleotide (< 100-400 base pair) combinatorial libraries from either the epidermal growth factor (EGF) ORF that encodes the > 1200 amino acid EGF precursor protein or the orphan ECRG4 ORF, that encodes a 148 amino acid Esophageal Cancer Related Gene 4 (ECRG4), a putative cytokine precursor protein of up to eight ligands. 31190084 2019
CUI: C0152018
Disease: Esophageal carcinoma
Esophageal carcinoma
0.100 GeneticVariation disease BEFREE In the stratified analysis by cancer types, the G allele and GG genotype of EGF +61A>G polymorphism showed displayed significant correlations with increased risk of esophageal cancer. 23403233 2013
CUI: C0152018
Disease: Esophageal carcinoma
Esophageal carcinoma
0.100 Biomarker disease BEFREE As a promoter of the malignant progression of esophageal cancer, epidermal growth factor (EGF) has been shown to induce EMT in several cell lines. 20413216 2010
CUI: C0152018
Disease: Esophageal carcinoma
Esophageal carcinoma
0.100 GeneticVariation disease BEFREE Gene-gene interaction of EGFR 497Arg>Lys and EGF +61A>G polymorphisms enhanced risk for EC, indicating additive effects. 18773861 2008
CUI: C0152018
Disease: Esophageal carcinoma
Esophageal carcinoma
0.100 Biomarker disease BEFREE Epidermal growth factor-induced esophageal cancer cell proliferation requires transactivation of beta-adrenoceptors. 18369180 2008
CUI: C0152018
Disease: Esophageal carcinoma
Esophageal carcinoma
0.100 GeneticVariation disease BEFREE The pilot study suggests that EGF +61AG and +61GG genotypes may predict clinical outcome in esophageal cancer patients treated with radiotherapy with or without chemotherapy. 17912028 2007
CUI: C0152018
Disease: Esophageal carcinoma
Esophageal carcinoma
0.100 AlteredExpression disease BEFREE IGFBP-3 secreted by cancer cells was capable of binding to insulin-like growth factor I. Functionally, epidermal growth factor appeared to regulate IGFBP-3 expression in esophageal cancer cell lines. 15520175 2004
CUI: C0152018
Disease: Esophageal carcinoma
Esophageal carcinoma
0.100 Biomarker disease BEFREE In addition to mitogenic ability, we demonstrate in this report that EGF protects a human esophageal carcinoma (CE) cell line, CE81T/VGH, from staurosporine-induced apoptosis. 10763823 2000
CUI: C0152018
Disease: Esophageal carcinoma
Esophageal carcinoma
0.100 Biomarker disease BEFREE Intratumoral heterogeneity of DNA ploidy and regional differences in epidermal growth factor and epidermal growth factor receptor of esophageal carcinoma. 8128479 1993
CUI: C0152018
Disease: Esophageal carcinoma
Esophageal carcinoma
0.100 AlteredExpression disease BEFREE Secondly, the effect of EGF and TGF alpha on the expression of these genes by the TE-1 esophageal carcinoma cell line was investigated. 8491760 1993
CUI: C0152018
Disease: Esophageal carcinoma
Esophageal carcinoma
0.100 AlteredExpression disease BEFREE Overexpression of epidermal growth factor and insulin-like growth factor-I receptors and autocrine stimulation in human esophageal carcinoma cells. 2004373 1991